{"entity":{"type":"insider","cik":"0001756228","url":"/insider/0001756228","json_url":"/insider/0001756228.json","name":"ALSTODT LANCE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":33,"first":"2019-08-22","last":"2023-09-18","span_basis":"filed_date"},"name_variants":[{"name":"ALSTODT LANCE","source":"filing","n_filings":33,"first_seen":"2019-08-22","last_seen":"2023-09-18"}],"transactions":[{"id":8400860,"accession":"0001021771-23-000096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001021771-23-000096","line_url":"/filing/0001021771-23-000096#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":3740.0,"total_display":"3,740.00","total_whole":"3,740","shares_owned_after":189505.0,"shares_owned_after_display":"189,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":8724625,"accession":"0001021771-23-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001021771-23-000090","line_url":"/filing/0001021771-23-000090#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":1.5325,"price_display":"1.53","price_state":"stated","total_value":1226.0,"total_display":"1,226.00","total_whole":"1,226","shares_owned_after":188105.0,"shares_owned_after_display":"188,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-13","scope":"insider"},{"id":8012482,"accession":"0001021771-23-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001021771-23-000088","line_url":"/filing/0001021771-23-000088#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2887.0,"shares_display":"2,887","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":5658.52,"total_display":"5,658.52","total_whole":"5,659","shares_owned_after":187305.0,"shares_owned_after_display":"187,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-06","scope":"insider"},{"id":8246496,"accession":"0001140361-23-036103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-036103","line_url":"/filing/0001140361-23-036103#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4200.0,"shares_display":"4,200","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":10248.0,"total_display":"10,248.00","total_whole":"10,248","shares_owned_after":184418.0,"shares_owned_after_display":"184,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-25","scope":"insider"},{"id":7978636,"accession":"0001567619-23-001697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-001697","line_url":"/filing/0001567619-23-001697#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":3.1034,"price_display":"3.10","price_state":"stated","total_value":1241.36,"total_display":"1,241.36","total_whole":"1,241","shares_owned_after":187321.0,"shares_owned_after_display":"187,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":8688945,"accession":"0001567619-23-001399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-001399","line_url":"/filing/0001567619-23-001399#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":3.01,"price_display":"3.01","price_state":"stated","total_value":602.0,"total_display":"602.00","total_whole":"602","shares_owned_after":186921.0,"shares_owned_after_display":"186,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-30","scope":"insider"},{"id":8616103,"accession":"0001567619-23-001186","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-23-001186","line_url":"/filing/0001567619-23-001186","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":3.135,"price_display":"3.14","price_state":"stated","total_value":627.0,"total_display":"627.00","total_whole":"627","shares_owned_after":186721.0,"shares_owned_after_display":"186,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-24","scope":"insider","n_lines":2},{"id":7849491,"accession":"0001567619-23-001056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-23-001056","line_url":"/filing/0001567619-23-001056","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":3.11075,"price_display":"3.11","price_state":"stated","total_value":1244.3,"total_display":"1,244.30","total_whole":"1,244","shares_owned_after":186321.0,"shares_owned_after_display":"186,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider","n_lines":3},{"id":7908663,"accession":"0001567619-23-000770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-000770","line_url":"/filing/0001567619-23-000770#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":308.0,"total_display":"308.00","total_whole":"308","shares_owned_after":186121.0,"shares_owned_after_display":"186,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":6634174,"accession":"0001567619-22-022055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-022055","line_url":"/filing/0001567619-22-022055","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":3.01,"price_display":"3.01","price_state":"stated","total_value":903.0,"total_display":"903.00","total_whole":"903","shares_owned_after":185921.0,"shares_owned_after_display":"185,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-23","filed_date":"2022-12-28","scope":"insider","n_lines":2},{"id":6523202,"accession":"0001567619-22-021408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-021408","line_url":"/filing/0001567619-22-021408#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":2.9861,"price_display":"2.99","price_state":"stated","total_value":5374.98,"total_display":"5,374.98","total_whole":"5,375","shares_owned_after":185721.0,"shares_owned_after_display":"185,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-07","scope":"insider"},{"id":6579809,"accession":"0001567619-22-020651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-020651","line_url":"/filing/0001567619-22-020651#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.8765,"price_display":"2.88","price_state":"stated","total_value":2876.5,"total_display":"2,876.50","total_whole":"2,877","shares_owned_after":183921.0,"shares_owned_after_display":"183,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":6160936,"accession":"0001567619-22-017754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-017754","line_url":"/filing/0001567619-22-017754","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":2.92,"price_display":"2.92","price_state":"stated","total_value":584.0,"total_display":"584.00","total_whole":"584","shares_owned_after":182821.0,"shares_owned_after_display":"182,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-22","filed_date":"2022-09-23","scope":"insider","n_lines":2},{"id":6761725,"accession":"0001567619-22-013928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013928","line_url":"/filing/0001567619-22-013928#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":2.95,"price_display":"2.95","price_state":"stated","total_value":2065.0,"total_display":"2,065.00","total_whole":"2,065","shares_owned_after":182721.0,"shares_owned_after_display":"182,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-12","filed_date":"2022-07-13","scope":"insider"},{"id":6828964,"accession":"0001567619-22-013553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013553","line_url":"/filing/0001567619-22-013553#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":3.0981,"price_display":"3.10","price_state":"stated","total_value":3407.91,"total_display":"3,407.91","total_whole":"3,408","shares_owned_after":182021.0,"shares_owned_after_display":"182,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-30","filed_date":"2022-07-01","scope":"insider"},{"id":6704875,"accession":"0001567619-22-013067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013067","line_url":"/filing/0001567619-22-013067#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":3.73,"price_display":"3.73","price_state":"stated","total_value":2238.0,"total_display":"2,238.00","total_whole":"2,238","shares_owned_after":180921.0,"shares_owned_after_display":"180,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-17","scope":"insider"},{"id":6659830,"accession":"0001567619-22-012910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-012910","line_url":"/filing/0001567619-22-012910#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":3.6822,"price_display":"3.68","price_state":"stated","total_value":2577.54,"total_display":"2,577.54","total_whole":"2,578","shares_owned_after":180321.0,"shares_owned_after_display":"180,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-15","scope":"insider"},{"id":6376430,"accession":"0001567619-22-012867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-012867","line_url":"/filing/0001567619-22-012867#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":3.9119,"price_display":"3.91","price_state":"stated","total_value":1955.95,"total_display":"1,955.95","total_whole":"1,956","shares_owned_after":179621.0,"shares_owned_after_display":"179,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-15","scope":"insider"},{"id":6659822,"accession":"0001567619-22-012812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-012812","line_url":"/filing/0001567619-22-012812","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":790.0,"total_display":"790.00","total_whole":"790","shares_owned_after":179021.0,"shares_owned_after_display":"179,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-14","scope":"insider","n_lines":2},{"id":6659803,"accession":"0001567619-22-012581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-012581","line_url":"/filing/0001567619-22-012581#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":428.0,"total_display":"428.00","total_whole":"428","shares_owned_after":178921.0,"shares_owned_after_display":"178,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-09","scope":"insider"},{"id":6255630,"accession":"0001567619-22-012211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-012211","line_url":"/filing/0001567619-22-012211#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":920.0,"total_display":"920.00","total_whole":"920","shares_owned_after":178821.0,"shares_owned_after_display":"178,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-03","scope":"insider"},{"id":6704800,"accession":"0001567619-22-011807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-011807","line_url":"/filing/0001567619-22-011807#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2700.0,"shares_display":"2,700","price_per_share":3.5163,"price_display":"3.52","price_state":"stated","total_value":9494.01,"total_display":"9,494.01","total_whole":"9,494","shares_owned_after":178621.0,"shares_owned_after_display":"178,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-27","scope":"insider"},{"id":6864556,"accession":"0001567619-22-009300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-009300","line_url":"/filing/0001567619-22-009300","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":3.947,"price_display":"3.95","price_state":"stated","total_value":1578.8,"total_display":"1,578.80","total_whole":"1,579","shares_owned_after":175921.0,"shares_owned_after_display":"175,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-02","scope":"insider","n_lines":2},{"id":6332091,"accession":"0001567619-22-001588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001588","line_url":"/filing/0001567619-22-001588#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1470.0,"shares_display":"1,470","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":4998.0,"total_display":"4,998.00","total_whole":"4,998","shares_owned_after":163083.0,"shares_owned_after_display":"163,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-24","scope":"insider"},{"id":6355171,"accession":"0001567619-22-000585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-000585","line_url":"/filing/0001567619-22-000585#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":7700.0,"total_display":"7,700.00","total_whole":"7,700","shares_owned_after":161613.0,"shares_owned_after_display":"161,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-05","scope":"insider"},{"id":4644247,"accession":"0001567619-21-021415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-021415","line_url":"/filing/0001567619-21-021415#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":799.0,"shares_display":"799","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":4394.5,"total_display":"4,394.50","total_whole":"4,395","shares_owned_after":159613.0,"shares_owned_after_display":"159,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider"},{"id":5157229,"accession":"0001567619-21-021072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-021072","line_url":"/filing/0001567619-21-021072#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":158814.0,"shares_owned_after_display":"158,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-23","scope":"insider"},{"id":4108844,"accession":"0001567619-21-020992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-020992","line_url":"/filing/0001567619-21-020992#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":396.0,"shares_display":"396","price_per_share":6.31,"price_display":"6.31","price_state":"stated","total_value":2498.76,"total_display":"2,498.76","total_whole":"2,499","shares_owned_after":156314.0,"shares_owned_after_display":"156,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-22","scope":"insider"},{"id":5157200,"accession":"0001567619-21-020595","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-020595","line_url":"/filing/0001567619-21-020595","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Director, Officer (President, CEO, COB)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, COB","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":6.711333333333333,"price_display":"6.71","price_state":"stated","total_value":30201.0,"total_display":"30,201.00","total_whole":"30,201","shares_owned_after":154218.0,"shares_owned_after_display":"154,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-16","scope":"insider","n_lines":4},{"id":8655906,"accession":"0001567619-19-018128","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-19-018128","line_url":"/filing/0001567619-19-018128","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Officer (EVP and Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.261,"price_display":"0.26","price_state":"stated","total_value":5220.0,"total_display":"5,220.00","total_whole":"5,220","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-10","scope":"insider","n_lines":4},{"id":8018600,"accession":"0001567619-19-018008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-018008","line_url":"/filing/0001567619-19-018008","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Officer (EVP and Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.26975,"price_display":"0.27","price_state":"stated","total_value":2697.5,"total_display":"2,697.50","total_whole":"2,698","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-05","filed_date":"2019-09-06","scope":"insider","n_lines":2},{"id":8074437,"accession":"0001567619-19-017607","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-19-017607","line_url":"/filing/0001567619-19-017607","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Officer (EVP and Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.2761,"price_display":"0.28","price_state":"stated","total_value":2761.0,"total_display":"2,761.00","total_whole":"2,761","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-27","scope":"insider","n_lines":3},{"id":7897662,"accession":"0001567619-19-017492","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-017492","line_url":"/filing/0001567619-19-017492","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001756228","owner_name":"ALSTODT LANCE","owner_display_name":"ALSTODT LANCE","owner_url":"/insider/0001756228","role":"Officer (EVP and Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Strategy Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.2498,"price_display":"0.25","price_state":"stated","total_value":2498.0,"total_display":"2,498.00","total_whole":"2,498","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-22","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":50,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001505497","name":"BioRestorative Therapies, Inc.","url":"/issuer/0001505497","role":"Director, Officer (President, CEO, COB), Ten percent owner","n_filings":33,"first_seen":"2019-08-22","last_seen":"2023-09-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001756228","retrieved_at":"2026-08-24T15:22:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}